> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Priority Review Voucher Awarded to Cannabidiol Maker
- URL: https://www.fdaweb.com/priority-review-voucher-awarded-to-cannabidiol-maker/
- Published: 2018-07-18T12:00:00.000Z
- Updated: 2026-09-15T00:20:01.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5141906

*Federal Register* notice: FDA has issued a priority review voucher for a rare pediatric disease product application — GW Research Ltd.’s Epidiolex(cannabidiol oral solution). The product is indicated for treating seizures associated with Dravet Syndrome or Lennox-Gastaut Syndrome in patients two years of age and older. To view the notice, click [here](https://s3.amazonaws.com/public-inspection.federalregister.gov/2018-15393.pdf?ref=fdaweb.com).